Blrce SRL
3.2 FTEBlrce reported total assets of €1.59m at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 3.2 full-time equivalents.
The score of Blrce shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -34 % Total assets +63 % Headcount (avg FTE) +19 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Blrce's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 11 Apr 2022
Blrce's financial analysis
- Solvency16.5%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Blrce
Blrce's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0734.605.150
- VAT number
- BE0734605150
- Peppol
- Registered · 0208:0734605150 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2019
- Registered office
- 7860 Lessines
- Size
- Micro · 3.2 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Blrce (SRL) has been based in Lessines since 2019, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 7,484 € and equity of 262,951 €; its revenue is not published. With 3.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 16.5%, below the median of its sector (34.4%).
Companies similar to Blrce
Companies in the same business, of comparable size and area, outside its group.
- Pharma 2424 Manufacture of pharmaceutical preparations Charleroi · balance sheet 550,405 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Apotheek Paleis Retail sale of pharmaceutical products Antwerp · balance sheet €1.59m
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Offiplant Retail sale of pharmaceutical products Lessines · balance sheet €3.17m
- Thomas Paesen Retail sale of pharmaceutical products Oudsbergen · balance sheet €1.46m
- Bontemps Invest Retail sale of pharmaceutical products Brussels · balance sheet €1.45m
- Pharmacie Novapharma Retail sale of pharmaceutical products Saint-Gilles · balance sheet 657,188 €
Frequently asked questions about Blrce
What is the revenue of Blrce?
Blrce files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Blrce?
In Belgium, the VAT number is the company number prefixed with BE: BE0734605150 for Blrce, if the company is VAT-registered. Its company number (CBE) is 0734.605.150.
Where is the registered office of Blrce?
According to the CBE register, the registered office of Blrce is in 7860 Lessines.
What is the equity of Blrce?
At the close of the 2025 financial year, the equity of Blrce amounts to 262,951 €, a solvency of 16.5% of total assets.
How many people work at Blrce?
3.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Blrce?
The register lists 1 active mandates at Blrce. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Blrce
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →